COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
Wilson, Joyce A |
University of Saskatchewan | Operating Grant | $50,000
CIHR Saskatchewan 2021
Read More